Results 231 to 240 of about 28,272 (264)

The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophages. [PDF]

Cell Death Discov
Baverel V, Wang F, Garrido C, Kohli E.
europepmc   +1 more source

Severe angioedema requiring airway intervention following evolocumab administration: a case report. [PDF]

Am J Cardiovasc Dis
Mojahedi A, Friedman A, Idries I, Farid M, Ghannam M, Chadow H.   +5 more
europepmc   +1 more source

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial. [PDF]

RMD Open
Lend K, Twisk JW, Kumar N, Dijkshoorn B, Lampa J, Rudin A, Hetland ML, Uhlig T, Nordström D, Østergaard M, Gudbjornsson B, Sokka-Isler T, Grondal G, Hørslev-Petersen K, Nurmohamed MT, Frostegård J, van Vollenhoven RF.   +16 more
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Impact of a Physician-led Strike Early-Strike Strong Lipid-Lowering Protocol Incorporating PCSK9 Inhibitors for Patients with Acute Myocardial Infarction. [PDF]

J Atheroscler Thromb
Arai R, Hotsubo Y, Nakajima Y, Sumida R, Mizobuchi S, Migita S, Tanaka Y, Hori K, Fukumoto K, Ebuchi Y, Kojima K, Sudo M, Okumura Y.   +12 more
europepmc   +1 more source

Lerodalcibep: Another Crucial Addition to the Dyslipidaemia Arsenal. [PDF]

Rev Cardiovasc Med
Sahebkar A, Karav S, Almahmeed W, Jamialahmadi T.   +3 more
europepmc   +1 more source

Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8⁺ T cells. [PDF]

J Immunother Cancer
Liu B, Cai L, Yan Y, Mao C, Zhang X, He Y, Chen S, Liu L, Xu Z, Xu L, Wang F, Yu L, Danser AHJ, Lu X, Xing S.   +14 more
europepmc   +1 more source

Prescriber Uptake and Use of Novel Lipid-Lowering Therapies. [PDF]

J Am Heart Assoc
Hwang J, Peterson ED, Gupta A, Decicco E, Sarnes E, Navar AM.   +5 more
europepmc   +1 more source

Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention. [PDF]

Front Med (Lausanne)
Rottura M, Barbieri MA, Siniscalchi C, Di Micco P, Drago SFA, Gigliotti De Fazio M, Cicero AFG, Fogacci F, Armentaro G, Sciacqua A, Arcoraci V, Irrera N, Imbalzano E.   +12 more
europepmc   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source